National Academies Press: OpenBook
« Previous: 8 Envisioning the Future
Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×

References

Bainbridge, M. N., W. Wiszniewski, D. R. Murdock, J. Friedman, C. Gonzaga-Jauregui, I. Newsham, J. G. Reid, J. K. Fink, M. B. Morgan, M. C. Gingras, D. M. Muzny, L. D. Hoang, S. Yousaf, J. R. Lupski, and R. A. Gibbs. 2011. Whole-genome sequencing for optimized patient management. Science Translational Medicine 3(87):87re3.

Bansal, V., R. Tewhey, E. J. Topol, and N. J. Schork. 2011. The next phase in human genetics. Nature Biotechnology 29(1):38–39.

Bloss, C. S., N. J. Schork, and E. J. Topol. 2011. Effect of direct-to-consumer genomewide profiling to assess disease risk. New England Journal of Medicine 364(6):524–534.

Boguski, M. S., R. Arnaout, and C. Hill. 2009. Customized care 2020: How medical sequencing and network biology will enable personalized medicine. F1000 Biology Reports 1:73.

Brandt, J. T., S. L. Close, S. J. Iturria, C. D. Payne, N. A. Farid, C. S. Ernest, 2nd, D. R. Lachno, D. Salazar, and K. J. Winters. 2007. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. Journal of Thrombosis and Haemostasis 5(12):2429–2436.

Bustamante, C. D., E. G. Burchard, and F. M. De la Vega. 2011. Genomics for the world. Nature 475(7355):163–165.

Christensen, C. M. 1997. The innovator’s dilemma: When new technologies cause great firms to fail. Cambridge, MA: Harvard Business Press.

Coates, R., M. Williams, S. Melillo, and J. Gudgeon. 2011. Genetic testing for Lynch syndrome in individuals newly diagnosed with colorectal cancer to reduce morbidity and mortality from colorectal cancer in their relatives. PLoS Currents 3:RRN1246.

Collins, F. 2008. Departing U.S. genome institute director takes stock of personalized medicine. Science 320(5881):1272.

EGAPP (Evaluation of Genomic Applications in Practice and Prevention). 2009. Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Genetics in Medicine 11(1):15–20.

Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×

Gollust, S. E., E. S. Gordon, C. Zayac, G. Griffin, M. F. Christman, R. E. Pyeritz, L. Wawak, and B.A. Bernhardt. 2011. Motivations and perceptions of early adopters of personalized genomics: Perspectives from research participants. Public Health Genomics 15(1):22–30.

Gong, I. Y., R. G. Tirona, U. I. Schwarz, N. Crown, G. K. Dresser, S. Larue, N. Langlois, A. Lazo-Langner, G. Zou, D. M. Roden, C. M. Stein, M. Rodger, M. Carrier, M. Forgie, P. S. Wells, and R. B. Kim. 2011. Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood 118(11):3163–3171.

Green, E. D., and M. S. Guyer. 2011. Charting a course for genomic medicine from base pairs to bedside. Nature 470(7333):204–213.

Hagenkord, J. M., F. A. Monzon, S. F. Kash, S. Lilleberg, Q. Xie, and J. A. Kant. 2010. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: Performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. Journal of Molecular Diagnostics 12(2):184–196.

Hughes, A. R., W. R. Spreen, M. Mosteller, L. L. Warren, E. H. Lai, C. H. Brothers, C. Cox, A. J. Nelsen, S. Hughes, D. E. Thorborn, B. Stancil, S. V. Hetherington, D. K. Burns, and A. D. Roses. 2008. Pharmacogenetics of hypersensitivity to abacavir: From PGx hypothesis to confirmation to clinical utility. The Pharmacogenomics Journal 8(6):365–374.

Jaeken, J. 2011. Congenital disorders of glycosylation (CDG): It’s (nearly) all in it! Journal of Inherited Metabolic Disease 34(4):853–858.

Jones, S. J., J. Laskin, Y. Y. Li, O. L. Griffith, J. An, M. Bilenky, Y. S. Butterfield, T. Cezard, E. Chuah, R. Corbett, A. P. Fejes, M. Griffith, J. Yee, M. Martin, M. Mayo, N. Melnyk, R. D. Morin, T. J. Pugh, T. Severson, S. P. Shah, M. Sutcliffe, A. Tam, J. Terry, N. Thiessen, T. Thomson, R. Varhol, T. Zeng, Y. Zhao, R. A. Moore, D. G. Huntsman, I. Birol, M. Hirst, R. A. Holt, and M. A. Marra. 2010. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biology 11(8):R82.

Kohane, I. S., K. D. Mandl, P. L. Taylor, I. A. Holm, D. J. Nigrin, and L. M. Kunkel. 2007. Medicine: Reestablishing the researcher–patient compact. Science 316(5826):836–837.

Lindhurst, M. J., J. C. Sapp, J. K. Teer, J. J. Johnston, E. M. Finn, K. Peters, J. Turner, J. L. Cannons, D. Bick, L. Blakemore, C. Blumhorst, K. Brockmann, P. Calder, N. Cherman, M. A. Deardorff, D. B. Everman, G. Golas, R. M. Greenstein, B. M. Kato, K. M. Keppler-Noreuil, S. A. Kuznetsov, R. T. Miyamoto, K. Newman, D. Ng, K. O’Brien, S. Rothenberg, D. J. Schwartzentruber, V. Singhal, R. Tirabosco, J. Upton, S. Wientroub, E. H. Zackai, K. Hoag, T. Whitewood-Neal, P. G. Robey, P. L. Schwartzberg, T. N. Darling, L. L. Tosi, J. C. Mullikin, and L. G. Biesecker. 2011. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. New England Journal of Medicine 365(7):611–619.

Lohmueller, K. E., A. R. Indap, S. Schmidt, A. R. Boyko, R. D. Hernandez, M. J. Hubisz, J. J. Sninsky, T. J. White, S. R. Sunyaev, R. Nielsen, A. G. Clark, and C. D. Bustamante. 2008. Proportionally more deleterious genetic variation in European than in African populations. Nature 451(7181):994–997.

Lupski, J. R., J. G. Reid, C. Gonzaga-Jauregui, D. Rio Deiros, D. C. Chen, L. Nazareth, M. Bainbridge, H. Dinh, C. Jing, D. A. Wheeler, A. L. McGuire, F. Zhang, P. Stankiewicz, J. J. Halperin, C. Yang, C. Gehman, D. Guo, R. K. Irikat, W. Tom, N. J. Fantin, D. M. Muzny, and R. A. Gibbs. 2010. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. New England Journal of Medicine 362(13):1181–1191.

Lyssenko, V., A. Jonsson, P. Almgren, N. Pulizzi, B. Isomaa, T. Tuomi, G. Berglund, D. Altshuler, P. Nilsson, and L. Groop. 2008. Clinical risk factors, DNA variants, and the development of type 2 diabetes. New England Journal of Medicine 359(21):2220–2232.

Mardis, E. R. 2006. Anticipating the 1,000 dollar genome. Genome Biology 7(7):112.

Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×

Ned, R. M. 2010. Genetic testing for CYP450 polymorphisms to predict response to clopidogrel: Current evidence and test availability. Application: Pharmacogenomics. PLoS Currents 2:RRN1180.

Nelson, D. L., and R. A. Gibbs. 2009. X-cess of variants in XLMR. Nature Genetics 41(5):510–512.

Ng, S. B., K. J. Buckingham, C. Lee, A. W. Bigham, H. K. Tabor, K. M. Dent, C. D. Huff, P. T. Shannon, E. W. Jabs, D. A. Nickerson, J. Shendure, and M. J. Bamshad. 2010. Exome sequencing identifies the cause of a Mendelian disorder. Nature Genetics 42(1):30–35.

PCAST (President’s Council of Advisors on Science and Technology). 2010. Realizing the full potential of health information technology to improve healthcare for Americans: The path forward. December 8. Available at http://www.whitehouse.gov/sites/default/files/microsites/ostp/pcast-health-it-report.pdf (accessed October 15, 2011).

Peat, R. A., J. M. Smith, A. G. Compton, N. L. Baker, R. A. Pace, D. J. Burkin, S. J. Kaufman, S. R. Lamande, and K. N. North. 2008. Diagnosis and etiology of congenital muscular dystrophy. Neurology 71(5):312–321.

Richards, C. S., S. Bale, D. B. Bellissimo, S. Das, W. W. Grody, M. R. Hegde, E. Lyon, and B. E. Ward. 2008. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genetics in Medicine 10(4):294–300.

Ripatti, S., E. Tikkanen, M. Orho-Melander, A. S. Havulinna, K. Silander, A. Sharma, C. Guiducci, M. Perola, A. Jula, J. Sinisalo, M. L. Lokki, M. S. Nieminen, O. Melander, V. Salomaa, L. Peltonen, and S. Kathiresan. 2010. A multilocus genetic risk score for coronary heart disease: Case-control and prospective cohort analyses. Lancet 376(9750):1393–1400.

Rope, A. F., K. Wang, R. Evjenth, J. Xing, J. J. Johnston, J. J. Swensen, W. E. Johnson, B. Moore, C. D. Huff, L. M. Bird, J. C. Carey, J. M. Opitz, C. A. Stevens, T. Jiang, C. Schank, H. D. Fain, R. Robison, B. Dalley, S. Chin, S. T. South, T. J. Pysher, L. B. Jorde, H. Hakonarson, J. R. Lillehaug, L. G. Biesecker, M. Yandell, T. Arnesen, and G. J. Lyon. 2011. Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. American Journal of Human Genetics 89(1):28–43.

Sloan, J. L., J. J. Johnston, I. Manoli, R. J. Chandler, C. Krause, N. Carrillo-Carrasco, S. D. Chandrasekaran, J. R. Sysol, K. O’Brien, N. S. Hauser, J. C. Sapp, H. M. Dorward, M. Huizing, B. A. Barshop, S. A. Berry, P. M. James, N. L. Champaigne, P. de Lonlay, V. Valayannopoulos, M. D. Geschwind, D. K. Gavrilov, W. L. Nyhan, L. G. Biesecker, and C. P. Venditti. 2011. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. Nature Genetics 43(9):883–886.

St. Hilaire, C., S. G. Ziegler, T. C. Markello, A. Brusco, C. Groden, F. Gill, H. Carlson-Donohoe, R. J. Lederman, M. Y. Chen, D. Yang, M. P. Siegenthaler, C. Arduino, C. Mancini, B. Freudenthal, H. C. Stanescu, A. A. Zdebik, R. K. Chaganti, R. L. Nussbaum, R. Kleta, W. A. Gahl, and M. Boehm. 2011. NT5E mutations and arterial calcifications. New England Journal of Medicine 364(5):432–442.

Teml, A., E. Schaeffeler, K. R. Herrlinger, U. Klotz, and M. Schwab. 2007. Thiopurine treatment in inflammatory bowel disease: Clinical pharmacology and implication of pharmaco genetically guided dosing. Clinical Pharmacokinetics 46(3):187–208.

Tewhey, R., V. Bansal, A. Torkamani, E. J. Topol, and N. J. Schork. 2011. The importance of phase information for human genomics. Nature Reviews Genetics 12(3):215–223.

Torkamani, A., and N. J. Schork. 2008. Predicting functional regulatory polymorphisms. Bioinformatics 24(16):1787–1792.

Torkamani, A., N. Kannan, S. S. Taylor, and N. J. Schork. 2008. Congenital disease SNPs target lineage specific structural elements in protein kinases. Proceedings of the National Academy of Sciences USA 105(26):9011–9016.

Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×

Worthey, E. A., A. N. Mayer, G. D. Syverson, D. Helbling, B. B. Bonacci, B. Decker, J. M. Serpe, T. Dasu, M. R. Tschannen, R. L. Veith, M. J. Basehore, U. Broeckel, A. Tomita-Mitchell, M. J. Arca, J. T. Casper, D. A. Margolis, D. P. Bick, M. J. Hessner, J. M. Routes, J. W. Verbsky, H. J. Jacob, and D. P. Dimmock. 2011. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genetics in Medicine 13(3):255–262.

Zhou, S. F. 2009. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clinical Pharmacokinetics 48(11):689–723.

Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×
Page 65
Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×
Page 66
Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×
Page 67
Suggested Citation:"References." Institute of Medicine. 2012. Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13256.
×
Page 68
Next: Appendix A: Workshop Agenda »
Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary Get This Book
×
Buy Paperback | $37.00 Buy Ebook | $29.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The initial sequencing of the human genome, carried out by an international group of experts, took 13 years and $2.7 billion to complete. In the decade since that achievement, sequencing technology has evolved at such a rapid pace that today a consumer can have his or her entire genome sequenced by a single company in a matter of days for less than $10,000, though the addition of interpretation may extend this timeframe. Given the rapid technological advances, the potential effect on the lives of patients, and the increasing use of genomic information in clinical care, it is important to address how genomics data can be integrated into the clinical setting. Genetic tests are already used to assess the risk of breast and ovarian cancers, to diagnose recessive diseases such as cystic fibrosis, to determine drug dosages based on individual patient metabolism, and to identify therapeutic options for treating lung and breast tumors, melanoma, and leukemia.

With these issues in mind and considering the potential impact that genomics information can have on the prevention, diagnosis, and treatment of disease, the Roundtable on Translating Genomic-Based Research for Health hosted a workshop on July 19, 2011, to highlight and identify the challenges and opportunities in integrating large-scale genomic information into clinical practice.

Integrating Large-Scale Genomic Information into Clinical Practice summarizes the speaker presentations and the discussions that followed them. This report focuses on several key topics, including the analysis, interpretation, and delivery of genomic information plus workforce, ethical, and legal issues.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!